搜索临床试验以:gamma interferon
总计2454个结果
-
Purdue FrederickWalter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement...完全的
-
National Institute on Drug Abuse (NIDA)University of Washington完全的
-
Sun Yat-sen UniversityFirst People's Hospital of Foshan; Eighth Affiliated Hospital, Sun Yat-sen University招聘中
-
Merck KGaA, Darmstadt, GermanyGesellschaft für Therapieforschung mbH完全的
-
Merck KGaA, Darmstadt, GermanyGesellschaft für Therapieforschung mbH完全的
-
Bayer完全的
-
National Institute of Allergy and Infectious Diseases...完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)完全的
-
Wen-hong ZhangThe First Affiliated Hospital with Nanjing Medical University; The First Affiliated Hospital... 和其他合作者尚未招聘
-
National Institute of Diabetes and Digestive and...完全的
-
King Abdulaziz Medical City完全的
-
Bayer完全的
-
French National Agency for Research on AIDS and...Hoffmann-La Roche完全的
-
Vir Biotechnology, Inc.Alnylam Pharmaceuticals主动,不招人
-
Kexing Biopharm Co., Ltd.The Third Hospital of Changsha; Guoxin Pharmaceutical Technology (Beijing) Co., Ltd.; Beijing... 和其他合作者完全的
-
Seoul National University HospitalRoche Pharma AG; SciClone Pharmaceuticals完全的
-
Teva Branded Pharmaceutical Products R&D, Inc.撤销
-
Bayer完全的多发性硬化症火鸡, 捷克语, 匈牙利, 以色列, 德国, 法国, 比利时, 希腊, 荷兰, 埃及, 哈萨克斯坦, 阿根廷, 葡萄牙, 阿尔及利亚, 沙特阿拉伯, 阿尔巴尼亚, 突尼斯
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)完全的未明确的儿童实体瘤,具体方案 | 恶性潜能未定的肿瘤美国
-
Intarcia Therapeutics完全的
-
Anhui Medical UniversityFirst Affiliated Hospital Bengbu Medical College; The Second Hospital of Anhui Medical University 和其他合作者招聘中
-
The Wistar InstituteUniversity of Pennsylvania; Merck Sharp & Dohme LLC完全的
-
Merck KGaA, Darmstadt, GermanyMerck Serono Australia Pty Ltd完全的
-
National Institute of Neurological Disorders and...完全的
-
University of Alabama at BirminghamNational Cancer Institute (NCI)完全的
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI); NCIC Clinical Trials Group; Children's Oncology Group; Cancer and... 和其他合作者主动,不招人